NKCFO LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,243
| Closed | -$3.83M | – | 134 |
|
|
2024
Q3 | $3.83M | Hold |
8,243
| – | – | 1.83% | 15 |
|
|
2024
Q2 | $3.86M | Sell |
8,243
-147
| -2% | -$68.9K | 2.11% | 12 |
|
|
2024
Q1 | $3.51M | Sell |
8,390
-35
| -0.4% | -$14.6K | 2.09% | 13 |
|
|
2023
Q4 | $3.43M | Hold |
8,425
| – | – | 1.86% | 15 |
|
|
2023
Q3 | $2.93M | Hold |
8,425
| – | – | 1.63% | 16 |
|
|
2023
Q2 | $2.97M | Sell |
8,425
-160
| -2% | -$56.3K | 1.37% | 22 |
|
|
2023
Q1 | $2.71M | Hold |
8,585
| – | – | 1.3% | 22 |
|
|
2022
Q4 | $2.48M | Buy |
8,585
+70
| +0.8% | +$20.2K | 1.16% | 24 |
|
|
2022
Q3 | $2.47M | Hold |
8,515
| – | – | 1.14% | 28 |
|
|
2022
Q2 | $2.4M | Buy |
8,515
+40
| +0.5% | +$11.3K | 0.84% | 31 |
|
|
2022
Q1 | $2.21M | Buy |
8,475
+8,025
| +1,783% | +$2.09M | 0.69% | 33 |
|
|
2021
Q4 | $99K | Buy |
+450
| New | +$99K | 0.03% | 87 |
|